skip to the content

Clinical Trials

Peritoneal Cancer Study

GOG 0212: A Randomized Phase III trial of maintenance Chemotherapy comparing 12 monthly cycles of single agent Paclitaxel or Xyotax (CT-2103) vs. no treatment until documented relapse in women with advanced ovarian or primary Peritoneal Cancer

Protocol ID

07.06.073

Protocol Description

The purpose of this study is to examine whether women with advanced ovarian cancer who have no evidence of disease after the completion of initial chemotherapy live longer if a specific treatment program is continued once a month for 12 months versus stopping all chemotherapy until there is evidence of recurrence of the disease process. There are three arms to this study: two different chemotherapy regimen arms and one arm which will receive no further treatment.

Eligibility Criteria

Women with ovarian or primary peritoneal cancer that has been confirmed by surgery.

Primary Investigator(s)

  • Veena John, MD

Contact Information

Laureen Thumser, RN
(516) 734-8979
lthumser@nshs.edu

Last Update

March 26, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Cancer:
top
top